Health CareHealth Care Equipment & Services
  • Price (USD)100.60
  • Today's Change0.71 / 0.71%
  • Shares traded897.11k
  • 1 Year change-8.16%
  • Beta0.8579
Data delayed at least 15 minutes, as of Aug 16 2019 21:02 BST.
More ▼

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

  • Revenue in USD (TTM)7.57bn
  • Net income in USD708.00m
  • Incorporated1996
  • Employees46.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DGX:NYQ since
Boyce & Bynum Pathology Laboratories-Clinical laboratory services businessDeal completed27 Nov 201827 Nov 2018Deal completed6.08%--
Marin General Hospital-Outreach Laboratory Service OperationsAnnounced25 Oct 201825 Oct 2018Announced9.99%--
PhenoPath Laboratories PLLCDeal completed27 Sep 201827 Sep 2018Deal completed-6.40%--
Oxford Immunotec Global PLC-Laboratory Services BusinessDeal completed25 Sep 201825 Sep 2018Deal completed-6.50%170.00m
Reprosource IncDeal completed24 Sep 201824 Sep 2018Deal completed-6.51%--
Data delayed at least 15 minutes, as of Aug 16 2019 21:02 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Chemed Corporation1.84bn200.97m6.85bn15.71k35.5611.0128.373.7312.0912.09110.5739.051.82210.1014.39116,971.9019.8813.8024.6317.7531.2030.0210.947.650.777245.340.139813.416.964.75128.7121.6312.518.83
Molina Healthcare, Inc.17.67bn792.00m8.57bn11.00k11.484.969.600.48511.9011.90265.4627.562.29--14.811,606,636.0010.251.5825.363.8617.8014.744.480.6301--10.500.47090.00-4.9923.45254.3773.61-21.09--
Davita Inc11.25bn547.52m9.27bn77.70k17.592.356.960.82363.290.812367.5624.620.571876.485.84144,842.603.714.455.565.6528.8029.146.486.881.102.810.6230.004.86-0.6183-6.17-0.12179.83--
Universal Health Services, Inc.11.06bn794.54m13.04bn78.70k16.922.4210.161.188.718.77120.8360.950.9695--7.00140,571.407.117.358.258.69----7.337.541.177.450.43145.373.487.897.028.6411.4214.87
Quest Diagnostics Inc7.57bn708.00m13.55bn46.00k19.532.4913.051.795.155.2955.0740.440.672950.147.07164,608.706.326.777.457.8035.1036.999.399.200.76736.870.415934.131.741.068.45-2.3810.6410.20
WellCare Health Plans, Inc.24.90bn523.80m13.80bn12.00k26.283.0017.920.554310.4410.38496.5591.502.13--25.072,075,100.004.493.738.916.9098.46--2.101.51--8.050.3110.0020.0316.4639.4520.3719.88--
Laboratory Corp. of America Holdings11.29bn882.70m16.23bn61.00k18.982.2711.341.448.768.46112.3373.050.659436.035.74185,109.805.165.175.975.9228.1331.017.837.211.056.850.48290.009.9514.3031.1410.1113.44--
Centene Corp69.54bn1.28bn19.86bn47.30k15.781.6310.670.28563.043.04165.7029.392.20--15.021,470,
Data as of Aug 16 2019. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

43.48%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 201914.77m10.97%
Macquarie Investment Management Business Trustas of 30 Jun 20197.94m5.90%
BlackRock Fund Advisorsas of 30 Jun 20197.28m5.40%
SSgA Funds Management, Inc.as of 30 Jun 20196.29m4.67%
American Century Investment Management, Inc.as of 30 Jun 20194.85m3.60%
Fiduciary Management, Inc.as of 30 Jun 20194.39m3.26%
Davis Selected Advisers LPas of 30 Jun 20194.00m2.97%
Boston Partners Global Investors, Inc.as of 30 Jun 20193.76m2.80%
Victory Capital Management, Inc.(Investment Management)as of 30 Jun 20193.19m2.37%
Geode Capital Management LLCas of 30 Jun 20192.09m1.55%
More ▼
Data from 30 Jun 2019 - 30 Jun 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.